UPC Analytics
DEEN
Übersicht · Eingereicht: 26. Aug. 2025

UPC_CoA_796/2025

BIOTELEMETRY DEVICE THAT CAN BE INGESTED AND IMPLANTED IN VIVO

BerufungenHauptberufungCourt of AppealAppealCase Closed
ÜbersichtEntscheidungenZitateDokumenteZeitverlauf
Parteien

Kläger

  • Bodycap
  • Centre National de la Recherche Scientifique (CNRS)
  • Université de Rennes
Vertreter: Geoffroy Cousin (FIDAL Innovation)

Beklagte

  • European Patent Office (EPO)
Richter
  • Emmanuel Gougé
Patente
  • EP3691518
CPC-Codes: A61B5/0031, A61B5/0537, A61B5/0507, A61B5/073, A61B1/041, A61B5/07, A61B5/7225, A61B5/0538

Sektor: Pharmaceutical & Medical

Ausgang
Abgewiesen
Eingereicht: 26. Aug. 2025
Erste Entscheidung: 16. Sept. 2025
Sprache: French

Court of Appeal dismissed Bodycap's appeal against the EPO's decision to reject the request for unitary effect. The CoA held that the application to annul the EPO's decision was groundless: the one-month period to correct deficiencies in a request for unitary effect (R.7(3) UPR) is non-extendable and expressly excluded from re-establishment of rights under R.22(6) UPR. Furthermore, interlocutory revision by the EPO (R.91 RoP) was excluded because the action under R.97 RoP constitutes an expedited action falling under the exception in R.85(2) RoP.

Im UPC-Register öffnen